BioSpace News Archive

Business

LEX Diagnostics Appoints Chief Technology Officer

LEX Diagnostics announces the appointment of Dr Heather Danks as its Chief Technology Officer.

July 18, 2023
·
2 min read
Deals

Viva Biotech’s Portfolio Company DTx Pharma Reached the Acquisition Agreement with Novartis

DTx Pharma, invested and incubated by Viva BioInnovator, is a preclinical stage biotechnology company addressing the delivery challenges of oligonucleotide therapeutics with its Fatty Acid Ligand Conjugated OligoNucleotide platform.

July 18, 2023
·
7 min read
Sobi publishes Q2 2023 report: Growth and pipeline expansion

Swedish Orphan Biovitrum AB announced its report for the second quarter 2023

July 18, 2023
·
3 min read
BioCapital

IGC Pharma, Inc. Presenting 6 Posters on the Positive Impact of IGC-AD1 on Neuropsychiatric Symptoms in Dementia at the 2023 Alzheimer’s Association International Conference

IGC Pharma, Inc. announced that it is presenting 6 in-person posters highlighting data from its Phase 1 clinical trials investigating the Company’s lead therapeutic candidate, IGC-AD1, at the Alzheimer’s Association International Conference being held July 16-20, 2023, in Amsterdam, Netherlands.

July 18, 2023
·
9 min read
Business

ProKidney Announces Closing of Purchase of Manufacturing Facility in Greensboro, NC

ProKidney Corp. announced it has closed on its purchase of a 210,000 square foot facility and approximately 22 acres of land in Greensboro, N.C. ProKidney paid approximately $25.5 million in cash for the facility and property.

July 18, 2023
·
5 min read
2nd ZAODX World Conference on Early Detection of Cancer to Take Place in September 2023

The 2nd ZAODX World Conference on Early Detection of Cancer will take place on-site at the Huangpu International Conference Center, Guangzhou, China, and online in a virtual format from 15 to 17 September, 2023.

July 18, 2023
·
2 min read
BioCapital

Angry@Arthritis Launches 1st Global Osteoarthritis Clinical Trial Locator

Angry@Arthritis, a nonprofit focused on attacking and eliminating Osteoarthritis, announced OA Fix ~Trials in the Mix, the first global OA developmental treatment analysis and clinical trial locator.

July 18, 2023
·
3 min read
Deals

Neurogene and Neoleukin Announce Definitive Merger Agreement

Neurogene Inc. and Neoleukin Therapeutics, Inc. announced that they have entered into a definitive merger agreement to combine the companies in an all-stock transaction.

July 18, 2023
·
20 min read
BioMidwest

EndoTheia Announces Successful Clinical Study Results for a Novel Medical Device for Endoscopic Surgery

EndoTheia, Inc. has announced the completion of a successful first-in-human clinical study performed at Vanderbilt University for their groundbreaking technology that radically improves minimally invasive endoscopic surgery.

July 18, 2023
·
3 min read
BSF Enterprise PLC Provides City-MixTM Bio-Pharmaceutical Update

BSF Enterprise PLC, a company focused on unlocking the next generation of biotechnological solutions using cell-based tissue engineering, provides a commercial update on the progress of City-MixTM, the flagship commercial product of its wholly owned subsidiary 3D Bio Tissues.

July 18, 2023
·
6 min read